drug
NICE recommendation for KORSERDU®▼ (elacestrant) marks ‘step-change’ in the treatment of ESR1-mutated metastatic breast cancer
December 19, 2024ESR1, Menari Group, NICE, breast cancer, drug
Elacestrant is the first tailored treatment for certain people with oestrogen receptor (ER)-positive HER2-negative locally advanced and metastatic breast cancer …
Merck, Novartis and Allergan to raise US drug prices, following most of drug industry
January 6, 2020Manufacturing and Production Allgeran, Big Pharma, Merck, Novartis, drug, drug prices
Following most of the large pharmaceutical companies, Merck, Novartis and Allergan have chosen to raise their drug prices. Novartis is …
Amgen slashes price of cholesterol drug Repatha by 60%
October 25, 2018Sales and Marketing Repatha, cholestrol, drug, medicine, pricing
American multinational Amgen has slashed the price of cholesterol drug Repatha, reducing the medication’s US list price by 60%. The …
Roche’s flu drug speeds up recovery in Phase III trial
October 4, 2018Research and Development Roche, drug, flu, pharma, recovery
Swiss multinational Roche’s flu drug baloxavir marboxil significantly sped up recovery time in comparison with placebo, in people at high …
FDA rejects Sunovion’s ADHD drug dasotraline
September 3, 2018Sales and Marketing ADHD, FDA, dasotraline, drug, sunovion
The US Food and Drug Administration (FDA) have rejected American pharma firm Sunovion’s application to market dasotraline for the treatment …
Researchers develop anti-nicotine addiction drugs
August 28, 2018Manufacturing and Production, Research and Development, Sales and Marketing addiction, candidates, drug, nicotine, research, washington state university
Washington State University researchers have developed an array of drug candidates which they believe may help tackle addiction to nicotine. …
Top Ten most popular articles on Pharmafile.com this week
November 3, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug, pharma, pharmaceuticals, top ten
As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …
Wave Life Sciences granted FDA orphan drug designation for Huntington’s disease drug
June 22, 2016Research and Development FDA, drug, huntington's disease, wave life sciences
Wave Life Sciences (NASDAQ: WVE) has announced that it has received orphan drug designation for the US Food and Drug …
Sun Pharma to partner with ICGEB to develop novel Dengue treatment
May 4, 2016Research and Development Dengue fever, Sun Pharma, collaboration, dengue, development, drug, icgeb, international centre for genetic engineering and biotechnology, partnership, sun pharmaceutical
Sun Pharmaceuticals (BSE: 85715) and the International Centre for Genetic Engineering and Biotechnology (ICGEB) are set to team up to …
Novartis drug Afinitor significantly reduces seizures in TSC patients
April 21, 2016Research and Development Afinitor, Novartis, Tuberous Sclerosis Complex, drug, seizure, seizures, tsc
Novartis (SIX: NOVN) has announced the results from a Phase III clinical trial which shows that Afinitor (everolimus) significantly reduced …
Roche’s cholesterol-lowering drug candidate shows promise in fighting prostate cancer
April 15, 2016Medical Communications, Research and Development RO 48-9071, Roche, cholesterol, drug, missouri, oncology, university
Researchers from the University of Missouri have found that a compound developed by Roche Pharmaceuticals for the treatment of high …
Tesaro shares rise as J&J buys rights to prostate cancer drug for $85 million
April 6, 2016Business Services, Research and Development, Sales and Marketing Cancer, J&J, JJ, M&A, MA, Tesaro, drug, licence agreement, research
Shares in oncology-focussed Tesaro Inc (Nasdaq: TSRO) jumped Wednesday after the company said pharma major Johnson & Johnson (NYSE: JNJ) …
FDA approves Bayer haemophilia A drug Kovaltry
March 17, 2016Research and Development, Sales and Marketing Bayer, FDA, approval, drug, drug approval, haemophilia, haemophilia a, kovaltry, viii compound
Bayer (ETR:BAYN) has received approval from the US Food and Drug Administration (FDA) for Kovaltry (octocog alfa), an unmodified, full-length …
FDA launches drug shortages app
March 6, 2015Medical Communications, Sales and Marketing Apple, FDA, app, drug, google, play, recall, shortages
The US Food and Drug Administration has launched its first smartphone app which provides valuable information about drug shortages. The …
Drug prices defy gravity – until patent expiry
June 23, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John LaMattina, LaMattina, Pfizer, drug, pharma, pricing, research
How drugs are priced is a hot topic these days, and a new Bloomberg article will cause it to heat-up …
Latest content
FibroFind appoints Lee Borthwick as CEO
